Intel 10-K 2022-12-31
Filed 2023-01-27. 14 sections, 650K characters. Original on sec.gov · Markdown · JSON
Cover and table of contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
(Mark One)
| ☑ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
| For the fiscal year ended December 31, 2022. | |||||
| or | |||||
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
| For the transition period from to . |
Commission File Number 000-06217

INTEL CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware | 94-1672743 | |||||||||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||||||||
| 2200 Mission College Boulevard, | Santa Clara, | California | 95054-1549 | |||||||||||
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (408) 765-8080
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol | Name of each exchange on which registered | ||||||||||||
| Common stock, $0.001 par value | INTC | Nasdaq Global Select Market |
Securities registered pursuant to Section 12(g) of the Act:
None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☑ No ☐
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☑
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐
Indicate by check mark whether the registrant has submitted electronically every interactive data file required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
| Large Accelerated Filer | Accelerated Filer | Non-Accelerated Filer | Smaller Reporting Company | Emerging Growth Company | |||||||||||||||||||
| ☑ | ☐ | ☐ | ☐ | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☑
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑
Aggregate market value of voting and non-voting common equity held by non-affiliates of the registrant as of July 1, 2022, based upon the closing price of the common stock as reported by the Nasdaq Global Select Market on such date, was $149.2 billion. 4,137 million shares of common stock were outstanding as of January 20, 2023.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the registrant’s proxy statement related to its 2023 Annual Stockholders' Meeting to be filed subsequently are incorporated by reference into Part III of this Form 10-K. Except as expressly incorporated by reference, the registrant's proxy statement shall not be deemed to be part of this report.
Table of Contents
Organization of Our Form 10-K
The order and presentation of content in our Form 10-K differs from the traditional SEC Form 10-K format. Our format is designed to improve readability and better present how we organize and manage our business. See "Form 10-K Cross-Reference Index" within the Financial Statements and Supplemental Details for a cross-reference index to the traditional SEC Form 10-K format.
We have defined certain terms and abbreviations used throughout our Form 10-K in "Key Terms" within the Financial Statements and Supplemental Details.
The preparation of our Consolidated Financial Statements is in conformity with US GAAP. Our Form 10-K includes key metrics that we use to measure our business, some of which are non-GAAP measures. See "Non-GAAP Financial Measures" within MD&A for an explanation of these measures and why management uses them and believes they provide investors with useful supplemental information.
| Fundamentals of Our Business | Page | |||||||
| Availability of Company Information | 2 | |||||||
| Introduction to Our Business | 3 | |||||||
| A Year in Review | 5 | |||||||
| Our Strategy | 7 | |||||||
| Our Capital | 10 | |||||||
| Management's Discussion and Analysis | ||||||||
| Our Products | 19 | |||||||
| Segment Trends and Results | 20 | |||||||
| Consolidated Results of Operations | 39 | |||||||
| Liquidity and Capital Resources | 44 | |||||||
| Critical Accounting Estimates | 47 | |||||||
| Non-GAAP Financial Measures | 47 | |||||||
| Other Key Information | ||||||||
| Sales and Marketing | 51 | |||||||
| Quantitative and Qualitative Disclosures About Market Risk | 52 | |||||||
| Risk Factors | 53 | |||||||
| Properties | [67](#i8aaa7b4dbd2e419ca0f |
Showing the first 8K of 640K characters. Open the full section
Item 1. Business:
Item 1B. Unresolved Staff Comments Not applicable
Item 4. Mine Safety Disclosures Not applicable
Item 6. [Reserved]
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations:
| | | | Liquidity and capital resources | | | Pages 5-6, 44-47, 47-51 | | | | | | | Results of operations | | | Pages 5-6, 19-44, 47-51 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Critical accounting estimates | | | Pages 47, 81-87 | | | | Item 7A. | | | Quantitative and Qualitative Disclosures About Market Risk | | | Page 52 | | | | Item 8. | | | Financial Statements and Supplementary Data | | | Pages 72-117 | | |
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure Not applicable
| Item 9A. | | | Controls and Procedures | | | Page 118 | | |
Item 9B. Other Information
| | | | Disclosure Pursuant to Section 13(r) of the Securities Exchange Act of 1934 | | | Page 71 | | |
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections Not applicable
| | | | | | | | | | | Part III | | | | | | | | | | Item 10. | | | Directors, Executive Officers, and Corporate Governance | | | Page 70, (a) | | |
Item 11. Executive Compensation (b)
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters (c)
Item 13. Certain Relationships and Related Transactions, and Director Independence (d)
Item 14. Principal Accountant Fees and Services (e)
Item 16. Form 10-K Summary Not applicable
| | | | | | | | | | | Signatures | | | | | | Page 125 | | |
(a) Incorporated by reference to "Director Nominees," "Director Nomination Process," "Board Committees," "Audit & Finance Committee," "Code of Conduct," "2024 Stockholder Proposals or Nominations," and "Delinquent Section 16(a) Reports" (if applicable) in the 2023 Proxy Statement. The information under the heading "Information about Our Executive Officers" within Other Key Information is also incorporated by reference in this section.
(b) Incorporated by reference to "Risk Oversight," "Director Compensation," "Compensation Discussion and Analysis," "Compensation Committee Report," "Executive Compensation Tables" "CEO Pay Ratio," and "Pay Versus Performance" in the 2023 Proxy Statement.
(c) Incorporated by reference to "Security Ownership of Certain Beneficial Owners and Management" and "Equity Compensation Plan Information" in the 2023 Proxy Statement.
(d) Incorporated by reference to "Director Independence and Transactions Considered in Independence Determinations" and "Certain Relationships and Related Transactions" in the 2023 Proxy Statement.
(e) Incorporated by reference to "2022 and 2021 EY Fees," "Report of the Audit & Finance Committee," and "Pre-Approval Policies" in the 2023 Proxy Statement.
![]() | Supplemental Details | 124 |
| Signatures | |||||
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| INTEL CORPORATION Registrant | |||||||||||
| By: | /s/ PATRICK P. GELSINGER | ||||||||||
| Patrick P. Gelsinger | |||||||||||
| Chief Executive Officer, Director, and Principal Executive Officer | |||||||||||
| January 26, 2023 |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| /s/ PATRICK P. GELSINGER | /s/ DAVID ZINSNER | |||||||||||||
| Patrick P. Gelsinger | David Zinsner | |||||||||||||
| Chief Executive Officer, Director, and Principal Executive Officer | Executive Vice President, Chief Financial Officer, and Principal | |||||||||||||
| Financial Officer | ||||||||||||||
| January 26, 2023 | January 26, 2023 | |||||||||||||
| /s/ SCOTT GAWEL | |||||
| Scott Gawel | |||||
| Corporate Vice President, Chief Accounting Officer and Principal Accounting Officer | |||||
| January 26, 2023 | |||||
| /s/ JAMES J. GOETZ | /s/ DR. TSU-JAE KING LIU | |||||||||||||
| James J. Goetz | Dr. Tsu-Jae King Liu | |||||||||||||
| Director | Director | |||||||||||||
| January 26, 2023 | January 26, 2023 | |||||||||||||
| /s/ DR. ANDREA J. GOLDSMITH | /s/ GREGORY D. SMITH | |||||||||||||
| Dr. Andrea J. Goldsmith | Gregory D. Smith | |||||||||||||
| Director | Director | |||||||||||||
| January 26, 2023 | January 26, 2023 | |||||||||||||
| /s/ ALYSSA HENRY | /s/ LIP-BU TAN | |||||||||||||
| Alyssa Henry | Lip-Bu Tan | |||||||||||||
| Director | Director | |||||||||||||
| January 26, 2023 | January 26, 2023 | |||||||||||||
| /s/ DR. OMAR ISHRAK | /s/ DION J. WEISLER | |||||||||||||
| Dr. Omar Ishrak | Dion J. Weisler | |||||||||||||
| Director | Director | |||||||||||||
| January 26, 2023 | January 26, 2023 | |||||||||||||
| /s/ DR. RISA LAVIZZO-MOUREY | /s/ FRANK D. YEARY | |||||||||||||
| Dr. Risa Lavizzo-Mourey | Frank D. Yeary | |||||||||||||
| Director | Chair of the Board and Director | |||||||||||||
| January 26, 2023 | January 26, 2023 | |||||||||||||
| /s/ BARBARA G NOVICK | ||||||||||||||
| Barbara G. Novick | ||||||||||||||
| Director | ||||||||||||||
| January 26, 2023 | ||||||||||||||
![]() | Supplemental Details | 125 |
